Development asset linked to SUBSTIPHARM in public FDA and regional records.
pharma · None - Healthy subjects
SUBSTIPHARM
Substipharm
SUBSTIPHARM drug portfolio — 3 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Paris, FR HQ
1995 Founded
157 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Paris, FR
- Founded
- 1995
- Employees
- 157
- Programs
- 1
- Drugs
- 3
- Patents
- 0
SUBSTIPHARM pipeline
Portfolio lens on 3 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
SUBSTIPHARM drug portfolio — 3 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to SUBSTIPHARM in public FDA and regional records.
-
Development asset linked to SUBSTIPHARM in public FDA and regional records.